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Uropathogenic Escherichia coli strains designated as ONAP, based on their 0 negative A positive agglutination of human 
Pi erythrocytes, were shown to prefer the globo-A glycolipid as a receptor structure. The dependence on both the A 
terminal and the globoseries chain was confirmed by agglutination of human AP,, but not Ap or OP, erythrocytes 
and by binding to the globo-A glycolipid on TLC plates. Neither Gala1 +4GalB nor the A trisaccharide GalNAcul+ 
3(Fucal+2)Gal~ alone functioned as receptors. The bacteria thus appeared to recognize an epitope resulting from the 
combination of the terminal and internal structures. 
Bacterial attachment, Glycolipid receptor; Globoseries; (E. CO/I’) 
1. INTRODUCTION 2. MATERIALS AND METHODS 
Glycoconjugates erve as receptors for microbial 
ligands such as viral binding proteins, bacterial 
toxins and adhesins [l-3]. One well-characterized 
receptor for attaching bacteria is the Galcul+ 
4Gal/3 disaccharide moiety of the globoseries of 
glycolipids [4,5]. The Galcvl+4Gal@ reactive 
strains agglutinate latex beads coupled with syn- 
thetic Galcvl-+4Galf3 [ 161 and bind to glycolipids 
containing this sequence separated on thin-layer 
chromatograms (TLC) [7]. They also agglutinate 
human Pi and PZ but not p erythrocytes which lack 
serologically detectable amounts of the globoseries 
of glycolipids [4,5,8]. We recently identified a 
group of E. coli isolates which agglutinated human 
Pi, but not p erythrocytes or Galal-+4Gal,&latex 
beads (Senior et al., to be published). The present 
study demonstrates that those strains recognize an 
epitope on the globoseries of glycolipids other than 
Gala1+4Gav alone, i.e. the globo-A structure. 
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The 82 E. coli isolates from the urine of dogs were stored and 
kept in deep agar stab cultures. 
Two type strains with known specificity for the globoseries of 
glycolipids were used: the wild-type isolate E. co/i 36692 [4,7] 
and E. coli 506MR, derived from the faecal isolate 506P by 
transformation with the chromosomal DNA fragment pap [9] 
encoding pili and adhesins specific for the globoseries of 
glycolipids. 
Erythrocytes from titrated human blood of groups API, OPI, 
BP, Ap and Op, were diluted to 3% suspensions (v/v) in 
phosphate-buffered saline (PBS) containing 2.5% cr-methyl- 
mannoside. Synthetic oligosaccharides were coupled to bovine 
serum albumin (BSA), covalently linked to latex beads [6]. 
Bacteria were cultured and agglutinations of erythrocytes and 
latex beads performed as described [6]. 
Total non-acid glycosphingolipid fractions [lo] and purified 
glycolipids [ll-141 from mouse and dog intestines, human 
meconium and erythrocytes were tested for binding activities. 
The structures of these glycolipids have all been confirmed by 
mass spectrometry (VG ZAB-HF. Manchester, England) of the 
permethylated erivatives. 
Crude glycolipid extracts were obtained from 1 ml of packed 
human erythrocytes of blood group Alp and Op which were 
mixed with methanol (1: 2, v/v), sonicated for 10 min, heated at 
70°C for 60 min and centrifuged at 3500 rpm for 10 min. The 
sediment was re-extracted with 2 ml methanol and with 1.5 ml 
chloroform/methanol (2 : 1, v/v). The pooled supernatants were 
adjusted to a solvent composition of chloroform/methanol/ 
water of 1: 10:9 (by vol.), and applied three times to 1 ml pre- 
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Table 1 
Agglutination of human erythrocytes in relation to A, B, H and 
P blood groups 
Hemagglutination Hemagglutination 
blood group 
Gahl+4Ga&latex agglutination 
-(n=16) +(n=9) 
AIPI +++ +++ 
BP1 +++ 
GP1 I:; +++ 
Alp _ - 
GP _ _ 
Hemagglutination reactions were performed in the presence of 
2.5% cu-methylmannoside. 
Table 2 
Agglutination of saccharide-latex bead conjugates by ONAP 
strains 
Saccharides, Receptor specificity 
ONAP* Galcvl -+4Gaub 
GaINA- +3(Fuccul-+2)Galp _ _ 
Galrvl-+4Gau _ ++ 
Galn1+4Gal@l-+4Gl$B _ ++ 
Gala1 +4Ga~l+4GlcNAc@ - ++ 
GaINA@ - _ 
GaINA@ +3Galo - _ 
GalNA@l-+3Gakul~ 
4Ga~l-+4Glcp + ++ 
“n=16 
b E. coli 36692 and 506MR 
2 
3 
4 
$ 
OR 
ABC D E F 
packed Bond Elute C-18 columns (Analytichem, Harbor City, 
CA) pre-conditioned in this solvent. The glycolipids were eluted 
with 10 ml chlorofom/methanol (2: 1, v/v), dried under 
nitrogen and resuspended in chloroform/methanol (2 : 1, v/v). 
Glycolipids were degraded using a mixture of extracellular a- 
glycosidases from Ruminococcus AB strain VI-268 at 37°C for 
72 h [12,15]. 
Antibody and bacterial overlay [7,12] was performed with 
slight modifications, using TLC plates treated with polyisobu- 
tylmethacrylate in diethyl ether/hexane (1: 1, v/v) or in pure 
diethyl ether at concentrations ranging from 0.15 to 0.35% 
(w/v) and bacteria grown in Luria broth with 1 mM CaC12 and 
50 pCi [“Slmethionine (500 ~1) at 37°C for 15-18 h suspended 
to approx. 10’ CFU/ml in PBS (spec. act. lOC-200 cpm/cfu). 
3. RESULTS 
Two categories of mannose-resistant adhesins 
were observed among the 82 E. coli isolates. Nine 
strains agglutinated PI erythrocytes and the 
Galcrl-+4Gal&latex beads but not p erythrocytes, 
and 16 strains agglutinated PI but not the p ery- 
throcytes or the GalcY1+4Gal&latex beads. The 
strains with Galcvl+4Galp_specific adhesins ag- 
glutinated all PI erythrocytes regardless of ABH 
blood group. The second category reacted with the 
ArPl erythrocytes but poorly with B or 0 erythro- 
cytes, and were designated as ONAP (0 negative, 
A positive, table 1). 
The ONAP strains did not react with the A 
trisaccharide or terminal Galcvl+4Gal,& disac- 
Fig. 1. TLC with 3 pg, respectively, of globotetraosylceramide with hydroxylated (lane A) and non-hydroxylated (lane B) ceramides; 
1 pg, P-Forssman glycolipid (lane C); 1 yg, globe-H (lane D); 2 pg respectively of blood group A hexa- and heptaglycosylceramides 
(lane E); and 20rg total non-acid glycolipids of meconium of a blood group 0 Lea-b + secretor individual (lane F). (a) Autoradiogram 
after overlay with 35S-labelled E. coli ONAP strain 1484. (b) Chemical detection of the glycolipid fractions as shown by copper acetate 
staining. 
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Fig.2. TLC of non-acid glycolipids of an 0 Lea-b+ secretor meconium sample (lane A), of blood group A hepta- and 
hexaglycosylceramide b fore (lanes B,D) and after 72 h of incubation with bacterial glycosidases (lanes C,E). (a) Chemical detection 
with copper acetate. (b) Autoradiogram after overlay with 35S-labelled E. coli strain 506MR. (c) Autoradiogram after overlay with 
ONAP strain 1484. Lane A was omitted from c. 
:haride as tested by agglutination of oligosacchar- 
Ide-latex bead conjugates, but reacted weakly with 
zlobotetraose-coupled beads (table 2). As expected 
the reactivity of the Galcvl+4Gal,&specific strains 
was exclusive for Galcv1+4Gal,&containing sac- 
zharides. 
Fig. 1 shows bacterial binding to a series of blood 
group A and globoseries-related glycolipids separ- 
ated on TLC plates. The ONAP strain bound 
OR. . . . 
ABCD 
strongly to glycolipids in the seven-sugar region of 
the fractions in lane E containing mainly blood 
group A active mono- and difucosylated hexa- and 
heptaglycosylceramides, as confirmed by staining 
with anti-A antibodies, and weakly to globotetra- 
osylceramides from meconium, to &Forssman. 
from erythrocytes and to globo-H from meconium. 
The identity of the heptaglycosylceramide as; 
globo-A was first indicated by mass spectrometry’ 
ABCD ABCD 
Fig.3. Thin-layer chromatograms of non-acid glycolipids from donors of blood groups Op (lane A), Ap (lane B), Ap (lane C), 
globotetraosylceramide (lane D). (a) Chemical detection with copper acetate. (b) Autoradiogram after overlay with anti-A antibody 
1201. (c) Autoradiogram after overlay with E. cob strain 1484. 
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of the permethylated sample, with specific ions [ 161 
at m/z 606 and 638 (terminal A trisaccharide deter- 
minant), m/z 85 1 and 883 (tetrasaccharide determi- 
nant), m/z 1087 (pentasaccharide), m/z 1291 and 
m/z 1495 (hexa- and heptasaccharide). Secondly, 
glycosidases of Ruminococcus AB, which degrade 
monofucosylated but not difucosylated blood 
group A active type 1 chain glycolipids to lac- 
totetraosylceramide, partially degraded the mono- 
fucosylated A hexaglycosylceramide, but not the 
difucosylated heptaglycosylceramide (fig.2a). The 
degradation of type 4 chain glycolipids was shown 
by the reactivity of both substrate and product, 
probably globopentaosylceramide, with E. coli 
506MR (fig.2b). The minor heptaglycosylceramide 
component was thus tentatively identified as globo- 
A. The ONAP strain bound to the substrate of the 
enzymatic degradation, i.e. globo-A, but not to the 
product globopentaosylceramide at the concentra- 
tions used (fig.2c). 
The lack of reactivity with A type 1 and A type 
2 chain glycolipids was confirmed using crude 
glycolipid extracts from Ap and Op erythrocytes, a 
non-acid glycolipid fraction of human meconium 
and a purified A-type 2 chain glycolipid (fig.3). 
4. DISCUSSION 
The present study has demonstrated specificity 
for the globo-A oligosaccharide sequence (table 1) 
among uropathogenic E. coli designated as ONAP 
based on 0 negative A positive hemagglutination. 
Like the previously known strains recognizing 
the globoseries of glycolipids, these isolates de- 
monstrated P blood group dependent hemagglutin- 
ation. In contrast, they did not bind Galcvl-+4Gal@ 
on latex beads and the P blood group related reac- 
tivity was limited to the A blood group. The strains 
with specificity for the Galcvl-+4Gal,& disaccharide 
bound with comparable intensity to all the natural 
Table 3 
Structure and receptor activities of glycolipids 
Structure Receptor activities 
E. co/i 
ONAP 
Lactosylceramide 
Galabiosylceramide 
Globotriaosylceramide 
Globotetraosylceramide (globoside) 
Globopentaosylceramide 
,&Forssman 
H type 4 chain (globo-H) 
A type 2 chain 
A type 1 chain 
ALeb (type 1 chain) 
A type 4 chain (globo-A) 
GaL61+4GlcCer _ 
Galcvl+4GalCer (+) 
G&l +4Gal,81*4GlcCer (+) 
GalNAq31+3Gakul+4G~l+4GlcCer (+) 
Gal,81+3GalNA~l~3GalcYl+4Ga~l-+4GlcCer n.d. 
GalNAc,81+3GalNA@l -t3Ga.l~l-+4Galpl-t4GlcCer (+) 
Gal,81 -+3GalNA~l+ 3Gal~1+4Ga491+4GlcCer (+) 
2 
t 
Fuccvl 
GaINAwl -+3Gal,&l-+4GlcNAc@l-r3Ga~1-*4GlcCer _ 
2 
t 
Fuccu 1
GaINAwl +3Ga~l~3GlcNAqf3I-+3Ga~1~4GlcCer - 
2 
t 
Fuccvl 
GalNA~l-+3G~l~3GlcNAq31-3Ga~1k+4GlcCer - 
2 4 
t t 
Fucczl Fuwl 
GaINAwl +3Ga~l+3GalNAq31 -t3Galul +4Gavl+4GlcCer + 
2 
t 
Fuccul 
E. coli 
506MR 
- 
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glycolipids containing this disaccharide. The 
3NAP strains bound strongly to globo A but 
weakly to globotetraosylceramide, the P-Forssman 
glycolipid hapten and the diglycosylceramide 
region on TLC plates. An influence of the A deter- 
minant per se was contradicted by the lack of reac- 
tivity with Ap erythrocytes, glycolipid extracts and 
with the synthetic A trisaccharide coupled to latex 
beads. The specificity for the globoseries showed 
that the Galtvl+4G@ moiety was required for the 
receptor conformation. These results suggest that 
the bacteria recognize a conformation afforded by 
the type 4 chains only, which is not satisfied by any 
of the tested terminal or internal di- or trisac- 
charide combinations. Recent evidence indicates 
stronger binding to cy-Forssman, suggesting that 
the binding epitope may be a terminal GalNAcc~ on 
an extended globoseries oligosaccharide common 
to Forssman and globo-A. It remains to be shown 
if this specificity is similar to that of the recently 
reported prs clone from E. coli 596 [17]. 
The specificity for globo-A was found in 19% of 
the E. coli strains from dogs with urinary tract in- 
fection and in a subgroup of human strains with 
globotetraosylceramide, but not Gahl-+4GahY 
reactivity [ 181. The functional importance of this 
specificity for adherence and infection remains to 
be established. 
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